BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37625134)

  • 1. Reversal of Experimental Autoimmune Diabetes With an sCD39/Anti-CD3 Treatment.
    Fotino C; Molano RD; Ben Nasr M; Umland O; Fraker CA; Ulissi U; Balasubramanian HB; Lunati ME; Usuelli V; Seelam AJ; Khalefa SA; La Sala C; Gimeno J; Mendez AJ; Ricordi C; Bayer AL; Fiorina P; Pileggi A
    Diabetes; 2023 Nov; 72(11):1641-1651. PubMed ID: 37625134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination treatment with anti-CD20 and oral anti-CD3 prevents and reverses autoimmune diabetes.
    Hu C; Ding H; Zhang X; Wong FS; Wen L
    Diabetes; 2013 Aug; 62(8):2849-58. PubMed ID: 23447122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
    Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
    J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses.
    Shevchenko I; Mathes A; Groth C; Karakhanova S; Müller V; Utikal J; Werner J; Bazhin AV; Umansky V
    Oncoimmunology; 2020 Apr; 9(1):1744946. PubMed ID: 33457090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet-Derived eATP Fuels Autoreactive CD8
    Tezza S; Ben Nasr M; D'Addio F; Vergani A; Usuelli V; Falzoni S; Bassi R; Dellepiane S; Fotino C; Rossi C; Maestroni A; Solini A; Corradi D; Giani E; Mameli C; Bertuzzi F; Pezzolesi MG; Wasserfall CH; Atkinson MA; Füchtbauer EM; Ricordi C; Folli F; Di Virgilio F; Pileggi A; Dhe-Paganon S; Zuccotti GV; Fiorina P
    Diabetes; 2018 Oct; 67(10):2038-2053. PubMed ID: 30065030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homotaurine Treatment Enhances CD4
    Tian J; Dang H; O'Laco KA; Song M; Tiu BC; Gilles S; Zakarian C; Kaufman DL
    Immunohorizons; 2019 Oct; 3(10):498-510. PubMed ID: 31636084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.
    Schuler PJ; Saze Z; Hong CS; Muller L; Gillespie DG; Cheng D; Harasymczuk M; Mandapathil M; Lang S; Jackson EK; Whiteside TL
    Clin Exp Immunol; 2014 Aug; 177(2):531-43. PubMed ID: 24749746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.
    Forsberg MH; Ciecko AE; Bednar KJ; Itoh A; Kachapati K; Ridgway WM; Chen YG
    J Immunol; 2017 May; 198(10):3857-3868. PubMed ID: 28363905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy.
    Zacca ER; Amezcua Vesely MC; Ferrero PV; Acosta CDV; Ponce NE; Bossio SN; Mussano E; Onetti L; Cadile I; Acosta Rodríguez EV; Montes CL; Gruppi A
    J Mol Biol; 2021 Jan; 433(1):166687. PubMed ID: 33098857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
    Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
    J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
    J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient Depletion of Foxp3
    Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
    Front Immunol; 2021; 12():720133. PubMed ID: 34447385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes.
    Jung S; Ben Nasr M; Bahmani B; Usuelli V; Zhao J; Sabiu G; Seelam AJ; Naini SM; Balasubramanian HB; Park Y; Li X; Khalefa SA; Kasinath V; Williams MD; Rachid O; Haik Y; Tsokos GC; Wasserfall CH; Atkinson MA; Bromberg JS; Tao W; Fiorina P; Abdi R
    Adv Mater; 2023 Oct; 35(40):e2300812. PubMed ID: 37357903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
    Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
    PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-33 prevents the development of autoimmune diabetes in NOD mice.
    Lu J; Liang Y; Zhao J; Meng H; Zhang X
    Int Immunopharmacol; 2019 May; 70():9-15. PubMed ID: 30780005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease.
    Kudryavtsev I; Serebriakova M; Zhiduleva E; Murtazalieva P; Titov V; Malashicheva A; Shishkova A; Semenova D; Irtyuga O; Isakov D; Mitrofanova L; Moiseeva O; Golovkin A
    Front Genet; 2019; 10():604. PubMed ID: 31402927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.